19-44894051-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001128917.2(TOMM40):c.628G>A(p.Val210Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000726 in 1,515,514 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128917.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000799 AC: 14AN: 175232Hom.: 0 AF XY: 0.0000648 AC XY: 6AN XY: 92558
GnomAD4 exome AF: 0.0000660 AC: 90AN: 1363180Hom.: 0 Cov.: 31 AF XY: 0.0000824 AC XY: 55AN XY: 667590
GnomAD4 genome AF: 0.000131 AC: 20AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.628G>A (p.V210I) alteration is located in exon 6 (coding exon 5) of the TOMM40 gene. This alteration results from a G to A substitution at nucleotide position 628, causing the valine (V) at amino acid position 210 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at